AIMS — Abnormal Involuntary Movement Scale

Rate highest severity observed: 0 = None, 1 = Minimal (may be extreme normal), 2 = Mild, 3 = Moderate, 4 = Severe.

Medication Context

Medications Add Medication

New Medication

Drug Name

e.g. Amoxicillin

Drug Code

RxNorm code...

Strength

e.g. 500 mg

Route

Select...

Frequency

Select...

Start Date

YYYY-MM-DD

Stop Date

YYYY-MM-DD

Notes

Notes / instructions...

Primary antipsychotic:

Duration on current regimen:

Prior AIMS score (if available):

Examination Procedure

Observed patient unobtrusively at rest

Mouth emptied (gum, candy removed)

Patient seated in hard chair, hands on knees

Hands hanging unsupported observed

Tongue at rest and protruded observed

Finger-thumb tapping (bilateral) completed

Standing, arms extended, and walking observed

1. Facial & Oral Movements

Area Rated	Score (0–4)	Findings
Muscles of Facial Expression (forehead, eyebrows, periorbital, cheeks)
Lips & Perioral Area (puckering, pouting, grimacing)
Jaw (biting, clenching, lateral movement)
Tongue (rate only increase in movement, in & out of mouth)

2. Extremity Movements

Area Rated	Score (0–4)	Findings
Upper Extremities (arms, wrists, hands, fingers)
Lower Extremities (legs, knees, ankles, toes)

3. Trunk Movements

Area Rated	Score (0–4)	Findings
Trunk Movements (neck, shoulders, hips — rocking, twisting, squirming)

4. Global Judgments

Global Rating	Score (0–4)	Notes
Severity of Abnormal Movements (overall)
Incapacitation Due to Abnormal Movements
Patient's Awareness of Movements (0=Unaware, 4=Severe distress)

Total AIMS score (items 1–7):

5. Dental Status

Dentures:

No dentures

Upper dentures

Lower dentures

Full dentures

Dental problems:

No current dental problems

Teeth/dentures bothering patient currently

Additional dental observations:

Clinical Summary & Plan

Clinical impression:

TD classification:

No evidence of TD

Possible TD (borderline scores)

Probable TD (≥2 in one area or ≥1 in two areas)

Definite TD

Medication plan:

Continue current regimen — no TD

Dose reduction considered

Switch to lower-risk agent

VMAT2 inhibitor (valbenazine / deutetrabenazine) considered

Neurology referral

Re-assessment interval:

Follow-up:

Counseling - AIMS (Abnormal Involuntary Movement Scale)

Preview